Amadio, Giulia
Amadio, Giulia
Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment
2017 Ferrandina, Gabriella; Amadio, Giulia; Marcellusi, Andrea; Azzolini, Elena; Puggina, Anna; Pastorino, Roberta; Ricciardi, Walter; Scambia, Giovanni
Real-world management of trabectedin/pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian cancer patients: A national survey
2017 Ferrandina, Gabriella; Amadio, Giulia; Paris, Ida; Distefano, Mariagrazia; Palluzzi, Eleonora; De Vincenzo, Rosa; Ricci, Caterina; Scambia, Giovanni
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study
2016 Petrillo, Marco; Amadio, Giulia; Salutari, Vanda; Paris, Ida; Di Stefano, M. G.; Ferandina, G.; Scambia, Giovanni; Fagotti, Anna
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial
2016 Lorusso, D; Scambia, Giovanni; Pignata, S; Sorio, R; Amadio, Giulia; Lepori, S; Mosconi, A; Pisano, C; Mangili, G; Maltese, Giustina; Sabbatini, R; Artioli, G; Gamucci, T; Di Napoli, M; Capoluongo, Ettore Domenico; Ludovini, V; Raspagliesi, F; Ferrandina, Maria Gabriella
Targeting the hallmarks of ovarian cancer: The big picture
2016 Petrillo, Marco; Nero, Camilla; Amadio, Giulia; Gallo, Daniela; Fagotti, Anna; Scambia, Giovanni
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study
2015 Petrillo, Marco; Paris, Ida; Vizzielli, Giuseppe; Amadio, Giulia; Cosentino, Francesco; Salutari, Vanda; Scambia, Giovanni; Fagotti, Anna
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence
2014 Mascilini, Floriana; Amadio, Giulia; Di Stefano, Mariagrazia; Ludovisi, Manuela; Di Legge, Alessia; Conte, Carmine; De Vincenzo, Rosa Pasqualina; Ricci, Caterina; Masciullo, Valeria; Salutari, Vanda; Scambia, Giovanni; Ferrandina, Maria Gabriella
Emerging drugs for endometrial cancer
2014 Amadio, Giulia; Masciullo, Valeria; Ferrandina, Maria Gabriella; Scambia, Giovanni
Controversy in treatment of advanced ovarian cancer
2013 Scambia, Giovanni; Salutari, Vanda; Amadio, Giulia
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2017 | Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment | Ferrandina, Gabriella; Amadio, Giulia; Marcellusi, Andrea; Azzolini, Elena; Puggina, Anna; Pastorino, Roberta; Ricciardi, Walter; Scambia, Giovanni | |
| 1-gen-2017 | Real-world management of trabectedin/pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian cancer patients: A national survey | Ferrandina, Gabriella; Amadio, Giulia; Paris, Ida; Distefano, Mariagrazia; Palluzzi, Eleonora; De Vincenzo, Rosa; Ricci, Caterina; Scambia, Giovanni | |
| 1-gen-2016 | Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study | Petrillo, Marco; Amadio, Giulia; Salutari, Vanda; Paris, Ida; Di Stefano, M. G.; Ferandina, G.; Scambia, Giovanni; Fagotti, Anna | |
| 1-gen-2016 | Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial | Lorusso, D; Scambia, Giovanni; Pignata, S; Sorio, R; Amadio, Giulia; Lepori, S; Mosconi, A; Pisano, C; Mangili, G; Maltese, Giustina; Sabbatini, R; Artioli, G; Gamucci, T; Di Napoli, M; Capoluongo, Ettore Domenico; Ludovini, V; Raspagliesi, F; Ferrandina, Maria Gabriella | |
| 1-gen-2016 | Targeting the hallmarks of ovarian cancer: The big picture | Petrillo, Marco; Nero, Camilla; Amadio, Giulia; Gallo, Daniela; Fagotti, Anna; Scambia, Giovanni | |
| 1-gen-2015 | Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study | Petrillo, Marco; Paris, Ida; Vizzielli, Giuseppe; Amadio, Giulia; Cosentino, Francesco; Salutari, Vanda; Scambia, Giovanni; Fagotti, Anna | |
| 1-gen-2014 | Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence | Mascilini, Floriana; Amadio, Giulia; Di Stefano, Mariagrazia; Ludovisi, Manuela; Di Legge, Alessia; Conte, Carmine; De Vincenzo, Rosa Pasqualina; Ricci, Caterina; Masciullo, Valeria; Salutari, Vanda; Scambia, Giovanni; Ferrandina, Maria Gabriella | |
| 1-gen-2014 | Emerging drugs for endometrial cancer | Amadio, Giulia; Masciullo, Valeria; Ferrandina, Maria Gabriella; Scambia, Giovanni | |
| 1-gen-2013 | Controversy in treatment of advanced ovarian cancer | Scambia, Giovanni; Salutari, Vanda; Amadio, Giulia |